"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
“More than any other provider group, primary care providers offer greater potential for expanding access to buprenorphine treatment,” says Dr. Mark Olfson.
Dr. Edward V. Nunes will serve as one of the directors of Columbia's Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN).
"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
"We were surprised to learn that there has been a larger decrease in opioid prescribing to adults with more rather than less severe pain," Dr. Mark Olfson said.
"Considering the high risk of suicide after nonfatal opioid overdose, this information could be especially valuable in suicide prevention efforts," Dr. Mark Olfson said.
'It's likely that the increasing use of illicit fentanyl has contributed to the rapid increase in unintentional opioid overdose deaths,' explained Dr Mark Olfson.
Opioid-related suicides account for only 4% of opioid-related deaths, far below previous estimates of 20% to 30%, a new study from Columbia University has found.
"The rate at which individuals relapsed and overdosed after ending treatment was alarmingly high, suggesting that discontinuing buprenorphine is a life-threatening event," said Dr. Williams.
Researchers at Columbia have developed a “Cascade of Care” model for treating individuals with opioid use disorder based on lessons learned in the HIV/AIDS field.